Memantine treatment for mild to severe Alzheimer's disease:: Clinical trials summary

被引：0

作者：

Tariot, PN

Doody, R

Peskind, ER

Winblad, B

Stöffler, A

Graham, SM

Jonas, JM

McDonald, S

机构：

[1] Univ Rochester, Med Ctr, Rochester, NY 14627 USA

[2] Baylor Coll Med, Houston, TX 77030 USA

[3] Univ Washington, Seattle, WA 98195 USA

[4] Huddinge Hosp, Karolinska Inst, S-14186 Huddinge, Sweden

来源：

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2004年 / 7卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

下载

页码：S381 / S381

页数：1

共 50 条

[21] Memantine for the treatment of Alzheimer's disease
Farlow, Martin R.
Graham, Stephen M.
Alva, Gustavo
DRUG SAFETY, 2008, 31 (07) : 577 - 585
[22] Cost effectiveness of memantine in the treatment of moderately severe and severe Alzheimer's disease in Spain
Antonanzas, F
Badenas, J
François, C
Guilhaume, C
VALUE IN HEALTH, 2003, 6 (06) : 765 - 765
[23] Meta-analysis of six-month memantine trials in Alzheimer's disease. Memantine has negligible benefits in mild to moderate Alzheimer's disease
Knopman, David S.
ALZHEIMERS & DEMENTIA, 2007, 3 (01) : 21 - 22
[24] Added Therapeutic Value of Memantine in the Treatment of Moderate to Severe Alzheimer’s Disease
T. Heinen-Kammerer
H. Rulhoff
S. Nelles
R. Rychlik
Clinical Drug Investigation, 2006, 26 : 303 - 314
[25] Added therapeutic value of memantine in the treatment of moderate to severe Alzheimer's disease
Heinen-Kammerer, T.
Rulhoff, H.
Nelles, S.
Rychlik, R.
CLINICAL DRUG INVESTIGATION, 2006, 26 (06) : 303 - 314
[26] Update of memantine safety in 6-month and long-term treatment of mild to severe Alzheimer's disease
Alva, Gustavo
FarloW, Martin R.
Porsteinsson, Anton
Graham, Stephen M.
BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 141S - 141S
[27] Memantine in the Treatment of Alzheimer’s Disease: 20 Years of Clinical Use
Gavrilova S.I.
Neuroscience and Behavioral Physiology, 2017, 47 (9) : 1071 - 1077
[28] Positive effects of memantine treatment in patients with moderate to severe Alzheimer's disease
Gauthier, S
Wirth, Y
Moebius, HJ
INTERNATIONAL PSYCHOGERIATRICS, 2005, 17 : 206 - 206
[29] Functional benefits of memantine treatment for patients with moderate to severe Alzheimer's disease
Wirth, Y
Doody, RS
Schmitt, FA
Möbius, HJ
NEUROBIOLOGY OF AGING, 2004, 25 : S205 - S205
[30] Functional effects of memantine treatment in patients with moderate to severe Alzheimer's disease
Wirth, Y.
Doody, R. S.
Schmitt, F. A.
Moebius, H. J.
Stoeffler, A.
EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 193 - 193

← 1 2 3 4 5 →